bioRxiv Science⌕ Search

Biology subjects

Gustafsson, M.

Publications and source records attributed to Gustafsson, M..

17 recordsLinked to original sources

Protein-protein interaction priors shape biologically coherent latent spaces for causally concordant cross-omic translation

Deep learning models routinely compress omics into low-dimensional codes, yet many equally accurate embeddings fail to reflect how cells are wired, which limits explanation and causal reasoning. We present a simple, architecture-agnostic approach to make latent spaces biologically legible: a protein-protein interaction (PPI) prior that softly steers autoencoder units to recruit genes that are proximal on the interactome while discouraging redundant reuse. Applied to large DNA methylation ([~]155k) and RNAseq ([~]993k) compendia and to knowledge-driven (STRING), structure-predicted (RoseTTAFold2-PPI), and union interactomes, this objective reorganizes methylation latents into compact, non-overlapping network neighborhoods without sacrificing reconstruction accuracy. The resulting units map cleanly onto biological processes such as cell-cycle control, immune signaling, proteostasis, mitochondrial metabolism, and RNA handling, with a limited, hub-enriched overlap that plausibly bridges modules. We then asked whether this structured geometry transfers downstream. Using paired TCGA cohorts spanning 23 cancers, omic translators trained on these embeddings, especially a shared-latent bidirectional model, outperformed full-matrix baselines in biologically concordant directions (methylation to transcription, genomics to methylation and transcription) and, crucially, inherited the mechanistic imprint of the upstream encoder. Analytical sensitivity mapping showed that translators fed PPI-guided embeddings preferentially learned known cancer drivers and enriched hallmark pathways, whereas accuracy-matched models trained on non-constrained embeddings did not. Thus, the prior not only regularizes but passes forward a functional coordinate system that makes subsequent predictors mechanistically aware. By keeping biology in the loss rather than hard-wiring it into the network, our approach scales to very large cohorts, preserves flexibility for understudied genes, and yields latents that are both performant and interpretable. More broadly, it outlines a practical route to mechanism-anchored representation learning that propagates explanatory structure into downstream tasks, advancing explainable AI for multi-omic analysis and clinical decision support.

bioinformatics↗

System-level health profiling from blood DNA methylation with explainable deep learning

Genome-scale DNA methylation (DNAm) profiles capture organismal physiology, but most predictive models lack transparency and multi-level applicability. Here we develop an explainable framework that quantifies respiratory, cardiovascular, and metabolic status as bounded health scores (0-1) derived from sex-specific clinical reference ranges and disease penalties, and then predicts these scores from whole-blood DNAm. Using Generation Scotland and case-control samples (n = 14,496 individuals), we screened 39 covariates for disease relevance and DNAm predictability, yielding system- relevant panels that were aggregated into scores. We compressed DNAm profiles with a protein-interaction-guided autoencoder, and trained health predictors on 128- dimensional embeddings using fully connected networks. On held-out samples, models reproduced the composite scores with strong rank agreement (Spearman {rho} = 0.87, R2 = 0.71 for respiratory health; {rho} = 0.82, R2 = 0.66 for cardiovascular; {rho} = 0.81, R2 = 0.64 for metabolic) and recover expected population structure in a generally healthy cohort, with clear separation between "single-system low" and "multi-system low" phenotypes, and graded coupling across systems without redundancy. Further, the top features retrieved from each explainable predictor aligned with system biology: airway epithelial repair, hypoxia and inflammatory trafficking for respiratory; endothelial remodeling and cardiomyocyte programs for cardiovascular; glucose-lipid metabolism and metaflammation for metabolic. These results show that DNAm embeddings can yield accurate, transparent, and system-aware health profiling from blood, providing actionable summaries while revealing the molecular processes the models use to infer multi-system status. This approach positions DNAm embeddings plus interpretable penalty targets as a practical bridge from epigenomic signal to system-level triage and is extensible for evaluation in larger, more diverse cohorts.

bioinformatics↗

scDrugPrio: A framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases

BackgroundIneffective drug treatment is a major problem for many patients with immune-mediated inflammatory diseases (IMIDs). Important reasons are the lack of systematic solutions for drug prioritisation and repurposing based on characterisation of the complex and heterogeneous cellular and molecular changes in IMIDs. MethodsHere, we propose a computational framework, scDrugPrio, which constructs network models of inflammatory disease based on single-cell RNA sequencing (scRNA-seq) data. scDrugPrio constructs detailed network models of inflammatory diseases that integrate information on cell type-specific expression changes, altered cellular crosstalk and pharmacological properties for the selection and ranking of thousands of drugs. ResultsscDrugPrio was developed using a mouse model of antigen-induced arthritis and validated by improved precision/recall for approved drugs, as well as extensive in vitro, in vivo, and in silico studies of drugs that were predicted, but not approved, for the studied diseases. Next, scDrugPrio was applied to multiple sclerosis, Crohns disease, and psoriatic arthritis, further supporting scDrugPrio through prioritisation of relevant and approved drugs. However, in contrast to the mouse model of arthritis, great interindividual cellular and gene expression differences were found in patients with the same diagnosis. Such differences could explain why some patients did or did not respond to treatment. This explanation was supported by the application of scDrugPrio to scRNA-seq data from eleven individual Crohns disease patients. The analysis showed great variations in drug predictions between patients, for example, assigning a high rank to anti-TNF treatment in a responder and a low rank in a nonresponder to that treatment. ConclusionWe propose a computational framework, scDrugPrio, for drug prioritisation based on scRNA-seq of IMID disease. Application to individual patients indicates scDrugPrios potential for personalised network-based drug screening on cellulome-, genome-, and drugome-wide scales. For this purpose, we made scDrugPrio into an easy-to-use R package (https://github.com/SDTC-CPMed/scDrugPrio).

immunology↗

Representational Learning from Healthy Multi-Tissue Human RNA-seq Data such that Latent Space Arithmetics Extracts Disease Modules

1Developing computational analyses of transcriptomic data has dramatically improved our understanding of complex multifactorial diseases. However, such approaches are limited to small sample sets of disease-affected material, thus being sensitive to statistical biases and noise. Here, we ask if a variational autoencoder (VAE) trained on large groups of healthy, human RNA-seq data of multiple tissues can capture the fundamental healthy gene regulation system such that the learned representation generalizes to account for unseen disease changes. To this end, we trained a multi-scale representation to encode cellular processes ranging from cell types to genegene interactions. Importantly, we found that the learned healthy representations could predict unseen gene expression changes from 25 independent disease datasets. We extracted and decoded disease-specific signals from the VAE latent space to dissect this finding. Interestingly, the gene modules corresponding to this signal contained more disease-specific genes than the respective differential expression analysis in 20 of 25 cases. Finally, we matched genes related to the disease signals to known drug targets. We could extract sets of known and potential pharmaceutical candidates from this analysis and demonstrate the utility in three use cases. In summary, our study showcases how data-driven representation learning using a VAE as a foundational model allows an arithmetic deconstruction of the latent space such that biological insights enable the dissection of disease mechanisms and drug targets. Our model is available at https://github.com/ddeweerd/VAE_Transcriptomics/.

systems biology↗

Data-driven representations using deep network-coherent methylation autoencoders to identify robust disease and risk factor signatures

Data analysis in systems medicine often employs knowledge-driven approaches, which leverage prior biological insights to guide and inform the study of large omic sets. However, the current state of knowledge in biology is still partial and biased. For example, cancer-associated genes are overrepresented in protein interaction networks. As a result, these approaches may fail to capture novel or unexpected phenomena. In this study, we present a data-driven workflow for the functional analysis of large DNA methylation data using deep autoencoders with biologically relevant latent embeddings (network-coherent autoencoders, NCAEs). We observed an increasing gene co-localization gradient, consistent with the human interactome, within the learned representation of a deep methylation autoencoder. We showcased the capacity of this coherent compressed space to discover signatures for classification associated with aging, smoking, and disease. We believe this approach can improve the understanding of complex epigenetic processes and help develop more effective diagnostic and therapeutic strategies.

bioinformatics↗

Identification and Characterization of Human Activation-Induced ChAT+CD4+ T Cells

Vasodilation is a cornerstone of inflammation physiology. By regulating vasodilation and tissue entry of T cells, CD4+ T lymphocytes expressing choline acetyltransferase (ChAT), a key enzyme for biosynthesis of the vasorelaxant acetylcholine (ACh), critically link immunity with vascular biology in mice. However, the characterization of primary human ChAT+ T cells remained elusive. Here, we identified human ChAT+ T cells and report that ChAT mRNA was induced by activation. Functional studies demonstrated that T cell-derived ACh increased muscarinic ACh-receptor dependent NO-synthase activity and vasorelaxation. Further, single-cell RNA-sequencing revealed ChAT+CD4+ T cells in blood from patients with severe circulatory failure and a high relative frequency of ChAT+CD4+ T cells correlated with better 30-day survival in this cohort. Our findings provide the first insights into ChAT biology in primary human T cells, linking ChAT+ T cells with vasorelaxation as well as survival in a cohort of critically ill patients.

immunology↗

White-box Deep Neural Network Prediction of Genome-Wide Transcriptome Signatures

Prediction algorithms for protein or gene structures, including transcription factor binding from sequence information, have been transformative in understanding gene regulation. Here we ask whether human transcriptomic profiles can be predicted solely from the expression of transcription factors (TFs). To this end, we explore whether a neural network (NN) could predict the transcriptome from TFs. Using at least one hidden layer, we find that the expression of 1,600 TFs can explain >95% of variance in 25,000 genes. Using the light-up technique to inspect the trained NN, we find an overrepresentation of known TF-gene regulations. Furthermore, the learned prediction network has a hierarchical organization. A smaller set of around 125 core TFs could explain close to 80% of the variance. Interestingly, reducing the number of TFs below 500 induces a rapid decline in prediction performance. Next, we evaluated the prediction model using transcriptional data from 22 human diseases. The TFs were sufficient to predict the target genes dysregulation (rho=0.61, P < 10-216). By inspecting the model, key causative TFs could be extracted for subsequent validation using disease-associated genetic variants. In conclusion, we demonstrate the construction of an interpretable neural network predictor. Analysis of the predictors revealed key TFs that were inducing transcriptional changes during disease.

systems biology↗

Progesterone specifically dampens disease-associated TH1- and TH17-related immune responses during T cell activation in vitro

The changes in progesterone (P4) levels during and after pregnancy coincide with the temporary improvement and worsening of several autoimmune diseases like multiple sclerosis (MS) and rheumatoid arthritis (RA). Most likely immune-endocrine interactions play a major role in these pregnancy-induce effects. In this study, we used next generation sequencing to investigate the direct effects of P4 on CD4+ T cell activation, of central importance in pregnancy and disease. We found that P4 had a profound dampening effect on T cell activation, altering the gene and protein expression profile and opposing many of the changes induced during the activation. The transcriptomic changes induced by P4 were significantly enriched for genes associated with diseases known to be modulated during pregnancy such as MS, RA and psoriasis. The TH1-and TH17-associated transcription factors STAT1 and STAT3 were significantly downregulated by P4 and their downstream targets were significantly enriched among the diseases-associated genes. Several of these genes included well-known and disease-relevant cytokines, such as IL-12{beta}, CXCL10 and OSM, that were further validated also at the protein level using proximity extension assay. Our results extend the previous knowledge of P4 as an immune regulatory hormone and supports its importance during pregnancy for regulating potentially detrimental immune responses towards the semi-allogenic fetus. Further, our results also point toward a potential role for P4 in the pregnancy-induced disease immunomodulation, suggestively through dampening of TH1 and TH17-associated immune responses and highlights the need for further studies evaluating P4 as a future treatment option.

immunology↗

Systematic GWAS-assessment of disease modules reveals a multi-omic MS module strongly associated with risk factors

BackgroundThere are few (if any) practical guidelines for predictive and falsifiable multi-omics data integration that systematically integrate existing knowledge. Disease modules are popular concepts for interpreting genome-wide studies in medicine but have so far not been systematically evaluated and may lead to corroborating multi-omic modules. MethodsWe assessed eight module identification methods in 57 previously published expression and methylation studies of 19 diseases using GWAS enrichment analysis. Next, we applied the same strategy for multi-omics integration of 19 datasets of multiple sclerosis (MS), and further validated the resulting module using both GWAS and risk-factor associated genes from several independent cohorts. ResultsOur benchmark of modules showed that in immune-associated diseases modules inferred from clique-based methods were the most enriched for GWAS-genes. The multi-omics case study using MS revealed the robust identification of a module of 220 genes. Strikingly, most genes of the module was differentially methylated upon the action of one or several environmental risk factors in MS (n = 217, P = 10-47) and were also independently validated for association with five different risk factors of MS, which further stressed the high genetic and epigenetic relevance of the module for MS. ConclusionWe believe our analysis provides a workflow for selecting modules and our benchmark study may help further improvement of disease module methods. Moreover, we also stress that our methodology is generally applicable for combining and assessing the performance of multi-omics approaches for complex diseases.

bioinformatics↗

Engineering of extracellular vesicles for display of protein biotherapeutics

Extracellular vesicles (EVs) have recently emerged as a highly promising cell-free bio-therapeutics. While a range of engineering strategies have been developed to functionalize the EV surface, current approaches fail to address the limitations associated with endogenous surface display, pertaining to the heterogeneous display of commonly used EV-loading moieties among different EV subpopulations. Here we present a novel engineering platform to display multiple protein therapeutics simultaneously on the EV surface. As proof-of-concept, we screened multiple endogenous display strategies for decorating the EV surface with cytokine binding domains derived from tumor necrosis factor receptor 1 (TNFR1) and interleukin 6 signal transducer (IL6ST), which can act as decoys for the pro-inflammatory cytokines TNF and IL6, respectively. Combining synthetic biology and systematic screening of loading moieties, resulted in a three-component system which increased the display and decoy activity of TNFR1 and IL6ST, respectively. Further, this system allowed for combinatorial functionalization of two different receptors on the same EV surface. These cytokine decoy EVs significantly ameliorated disease phenotypes in three different inflammatory mouse models for systemic inflammation, neuroinflammation, and intestinal inflammation. Importantly, significantly improved in vitro and in vivo efficacy of these engineered EVs was observed when compared directly to clinically approved biologics targeting the IL6 and TNF pathways.

bioengineering↗

ComHub: Community predictions of hubs in gene regulatory networks

SummaryHub transcription factors, regulating many target genes in gene regulatory networks (GRNs), play important roles as disease regulators and potential drug targets. However, while numerous methods have been developed to predict individual regulator-gene interactions from gene expression data, few methods focus on inferring these hubs. We have developed ComHub, a tool to predict hubs in GRNs. ComHub makes a community prediction of hubs by averaging over predictions by a compendium of network inference methods. Benchmarking ComHub to the DREAM5 challenge data and an independent data set of human gene expression, proved a robust performance of ComHub over all data sets. Lastly, we implemented ComHub to work with both predefined networks and to do standard network inference, which we believe will make it generally applicable. AvailabilityCode is available at https://gitlab.com/Gustafsson-lab/comhub Contactmika.gustafsson@liu.se, rasmus.magnusson@liu.se

bioinformatics↗

Deriving Disease Modules from the Compressed Transcriptional Space Embedded in a Deep Auto-encoder

Disease modules in molecular interaction maps have been useful for characterizing diseases. Yet biological networks, commonly used to define such modules are incomplete and biased toward some well-studied disease genes. Here we ask whether disease-relevant modules of genes can be discovered without assuming the prior knowledge of a biological network. To this end we train a deep auto-encoder on a large transcriptional data-set. Our hypothesis is that such modules could be discovered in the deep representations within the auto-encoder when trained to capture the variance in the input-output map of the transcriptional profiles. Using a three-layer deep auto-encoder we find a statistically significant enrichment of GWAS relevant genes in the third layer, and to a successively lesser degree in the second and first layers respectively. In contrast, we found an opposite gradient where a modular protein-protein interaction signal was strongest in the first layer but then vanishing smoothly deeper in the network. We conclude that a data-driven discovery approach, without assuming a particular biological network, is sufficient to discover groups of disease-related genes.

systems biology↗

LiPLike: Towards gene regulatory network predictions of high-certainty

MotivationReverse engineering of gene regulatory networks has for years struggled with high correlation in expression between regulatory elements. If two regulators have matching expression patterns it is impossible to differentiate between the two, and thus false positive identifications are abundant.\n\nResultsTo allow for gene regulation predictions of high confidence, we propose a novel method, LiPLike, that assumes a regression model and iteratively searches for interactions that cannot be replaced by a linear combination of other predictors. To compare the performance of LiPLike with other available inference methods, we benchmarked LiPLike using three independent datasets from the previous DREAM5 challenge. We found that LiPLike could be used to stratify predictions of other inference tools, and when applied to the predictions of DREAM5 participants we observed the accuracy to on average be improved >140% compared to individual methods. Furthermore, we observed that LiPLike independently predicted networks better than all DREAM5 participants when applied to biological data. When predicting the Escherichia coli network, LiPLike had an accuracy of 0.38 for the top-ranked 100 interactions, whereas the corresponding DREAM5 consensus model yielded an accuracy of 0.11.\n\nAvailabilityWe made LiPLike available to the community as a Python toolbox, available at https://gitlab.com/Gustafsson-lab/liplike. We believe that LiPLike will be used for high confidence predictions in studies where individual model interactions are of high importance, and that LiPLike will be used to remove false positive predictions made by other state-of-the-art gene-gene regulation prediction tools.\n\nContactrasmus.magnusson@liu.se, mika.gustafsson@liu.se

bioinformatics↗

On the prediction of protein abundance from RNA

BackgroundProfiling of mRNA expression is an important method to identify biomarkers but complicated by limited correlations between mRNA expression and protein abundance. We hypothesised that these correlations could be improved by mathematical models based on measuring splice variants and time delay in protein translation. MethodsWe characterised time-series of primary human naive CD4+ T cells during early T-helper type 1 differentiation with RNA-sequencing and mass-spectrometry proteomics. We then performed computational time-series analysis in this system and in two other key human and murine immune cell types. Linear mathematical mixed time-delayed splice variant models were used to predict protein abundances, and the models were validated using out-of-sample predictions. Lastly, we re-analysed RNA-Seq datasets to evaluate biomarker discovery in five T-cell associated diseases, validating the findings for multiple sclerosis (MS) and asthma. ResultsThe new models demonstrated median correlations of mRNA-to-protein abundance of 0.79-0.94, significantly out-performing models not including the usage of multiple splice variants and time-delays, as shown in cross-validation tests. Our mathematical models provided more differentially expressed proteins between patients and controls in all five diseases. Moreover, analysis of these proteins in asthma and MS supported their relevance. One marker, sCD27, was clinically validated in MS using two independent cohorts, for treatment response and prognosis. ConclusionOur splice variant and time-delay models substantially improved the prediction of protein abundance from mRNA data in three immune cell-types. The models provided valuable biomarker candidates, which were validated in clinical studies of MS and asthma. We propose that our strategy is generally applicable for biomarker discovery.

bioinformatics↗

An ex vivo tissue model of cartilage degradation suggests that cartilage state can be determined from secreted key protein patterns

The pathophysiology of osteoarthritis (OA) involves dysregulation of anabolic and catabolic processes associated with a broad panel of cytokines and other secreted proteins and ultimately lead to cartilage degradation. An increased understanding about the interactions of these proteins by means of systematic in vitro analyses may give new ideas regarding pharmaceutical candidates for treatment of OA and related cartilage degradation. Therefore, first an ex vivo tissue model of cartilage degradation was established by culturing full thickness tissue explants with bacterial collagenase II. Then responses of healthy and degrading cartilage were analyzed by measuring protein abundance in tissue supernatant with a 26-multiplex protein profiling assay, after exposing them to a panel of 55 protein stimulations present in synovial joints of OA patients. Multivariate data analysis including exhaustive pairwise variable subset selection was used to identify the most outstanding changes in the measured protein secretions. This revealed that the MMP9 response is outstandingly low in degraded compared to healthy cartilage and that there are several protein pairs like IFNG and MMP9 that can be used for successful discrimination between degraded and healthy samples. Taken together, the results show that the characteristic changes in protein responses discovered seem promising for accurate detection/diagnosis of degrading cartilage in general and OA in particular. More generally the employed ex vivo tissue model seems promising for drug discovery and development projects related to cartilage degradation, for example when trying to uncover the unknown interactions between secreted proteins in healthy and degraded tissues.

bioengineering↗

ModuleDiscoverer: Identification of regulatory modules in protein-protein interaction networks.

The identification of disease associated modules based on protein-protein interaction networks (PPINs) and gene expression data has provided new insights into the mechanistic nature of diverse diseases. A major problem hampering their identification is the detection of protein communities within large-scale, whole-genome PPINs. Current strategies solve the maximal clique enumeration (MCE) problem, i.e., the enumeration of all non-extendable groups of proteins, where each pair of proteins is connected by an edge. The MCE problem however is non-deterministic polynomial time hard and can thus be computationally overwhelming for large-scale, whole-genome PPINs.\n\nWe present ModuleDiscoverer, a novel approach for the identification of regulatory modules from PPINs in conjunction with gene-expression data. ModuleDiscoverer is a heuristic that approximates the community structure underlying PPINs. Based on a high-confidence PPIN of Rattus norvegicus and publicly available gene expression data we apply our algorithm to identify the regulatory module of a rat-model of diet induced non-alcoholic steatohepatitis (NASH). We validate the module using single-nucleotide polymorphism data from independent genome-wide association studies. Structural analysis of the module reveals 10 sub-modules. These sub-modules are associated with distinct biological functions and pathways that are relevant to the pathological and clinical situation in NASH.\n\nModuleDiscoverer is freely available upon request from the corresponding author.

systems biology↗

LASSIM - a network inference toolbox for genome-wide mechanistic modeling

Recent technological advancements have made time-resolved, quantitative, multi-omics data available for many model systems, which could be integrated for systems pharmacokinetic use. Here, we present large-scale simulation modeling (LASSIM), which is the first general mathematical tool for performing large-scale inference using mechanistically defined ordinary differential equations (ODE) for gene regulatory networks (GRNs). LASSIM integrates structural knowledge about regulatory interactions and non-linear equations with multiple steady states and dynamic response expression datasets. The rationale behind LASSIM is that biological GRNs can be simplified using a limited subset of core genes that are assumed to regulate all other gene transcription events in the network. LASSIM models are built in two steps, where each step can integrate multiple data-types, and the method is implemented as a general-purpose toolbox using the PyGMo Python package to make the most of multicore computers and high performance clusters, and is available at https://gitlab.com/Gustafsson-lab/lassim. As a method, LASSIM first infers a non-linear ODE system of the pre-specified core genes. Second, LASSIM optimizes the parameters that models the regulation of peripheral genes by core-system genes in parallel. We showed the usefulness of this method by applying LASSIM to infer a large-scale nonlinear model of naive Th2 differentiation, made possible by integrating Th2 specific bindings, time-series and six public and six novel siRNA-mediated knock-down experiments. ChIP-seq showed significant overlap for all tested transcription factors. Next, we performed novel time-series measurements of total T-cells during differentiation towards Th2 and verified that our LASSIM model could monitor those data significantly better than comparable models that used the same Th2 bindings. In summary, the LASSIM toolbox opens the door to a new type of model-based data analysis that combines the strengths of reliable mechanistic models with truly systems-level data. We exemplified the advantage by inferring the first mechanistically motivated genome-wide model of the Th2 transcription regulatory system, which plays an important role in the progression of immune related diseases.\n\nAuthor summaryThere are excellent methods to mathematically model time-resolved biological data on a small scale using accurate mechanistic models. Despite the rapidly increasing availability of such data, mechanistic models have not been applied on a genome-wide level due to excessive runtimes and the non-identifiability of model parameters. However, genome-wide, mechanistic models could potentially answer key clinical questions, such as finding the best drug combinations to induce an expression change from a disease to a healthy state.\n\nWe present LASSIM, which is a toolbox built to infer parameters within mechanistic models on a genomic scale. This is made possible due to a property shared across biological systems, namely the existence of a subset of master regulators, here denoted the core system. The introduction of a core system of genes simplifies the inference into small solvable subproblems, and implies that all main regulatory actions on peripheral genes come from a small set of regulator genes. This separation allows substantial parts of computations to be solved in parallel, i.e. permitting the use of a computer cluster, which substantially reduces the time required for the computation to finish.

systems biology↗